Strides Pharma arm receives USFDA nod for potassium chloride oral solution

Drug firm Strides Pharma Science on Monday said its step-down subsidiary, Strides Pharma Global Pte Ltd, has received approval from the US health regulator for potassium chloride for oral solution, used for prevention and treatment of low blood levels of potassium. The approved product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Potassium Chloride for Oral Solution USP, 20 mEq, of Pharma Research Software Solution, LLC.
Read more...

;